Clinical Trial

A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and glycemic control of SHR-3167 fixed-dose titration and individualized-dose titration in adults with Type 2 Diabetes inadequately controlled with oral antihyperglycemic agents.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-06-05
notable Enrollment increased: 90 -> 102 participants 2026-06-05
Trial Details
NCT Number NCT07472725
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Diabetes Mellitus, Type 2
Enrollment 102 participants
Start Date 2026-04-11
Primary Completion 2026-12 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-04